HS
ISEE

HighVista Strategies’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

HighVista Strategies’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-139,552
Closed -$5.49M – 172
2023
Q2 		$5.49M Buy
139,552
+41,458
+42% +$1.46M 2.51% 3
2023
Q1 		$2.39M Hold
98,094
– – 1.94% 19
2022
Q4 		$2.1M Buy
98,094
+64,034
+188% +$1.37M 1.25% 25
2022
Q3 		$611K Sell
34,060
-23,859
-41% -$313K 0.35% 75
2022
Q2 		$557K Buy
57,919
+4,336
+8% +$54.4K 0.34% 73
2022
Q1 		$902K Sell
53,583
-47,561
-47% -$703K 0.57% 45
2021
Q4 		$1.69M Buy
101,144
+38,037
+60% +$623K 1.35% 16
2021
Q3 		$1.02M Sell
63,107
-55,858
-47% -$608K 0.68% 50
2021
Q2 		$751K Sell
118,965
-22,090
-16% -$143K 0.53% 61
2021
Q1 		$872K Buy
141,055
+23,995
+20% +$146K 0.65% 24
2020
Q4 		$809K Buy
117,060
+21,085
+22% +$135K 0.52% 44
2020
Q3 		$541K Buy
+95,975
New +$458K 0.39% 42

HighVista Strategies's ISEE Position: Q3 2023 in Review

HighVista Strategies sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 139,552 shares — an estimated $5.49M sold.

HighVista Strategies first reported a position in ISEE in Q3 2020 and held it in 12 quarters. The position peaked at $5.49M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • HighVista Strategies reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • HighVista Strategies sold 139,552 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $5.49M.
  • HighVista Strategies first reported a position in IVERIC bio, Inc. Common Stock in Q3 2020 and held it in 12 quarters.
  • HighVista Strategies's IVERIC bio, Inc. Common Stock position peaked at $5.49M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on HighVista Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.